These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2320707)

  • 1. Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat.
    Gillberg PG; Hartvig P; Gordh T; Sottile A; Jansson I; Archer T; Post C
    Psychopharmacology (Berl); 1990; 100(4):464-9. PubMed ID: 2320707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
    Khan IM; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 1994 Jul; 270(1):150-8. PubMed ID: 8035311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists.
    Khan IM; Buerkle H; Taylor P; Yaksh TL
    Neuropharmacology; 1998 Dec; 37(12):1515-25. PubMed ID: 9886674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented responses to intrathecal nicotinic agonists in spontaneous hypertension.
    Khan IM; Printz MP; Yaksh TL; Taylor P
    Hypertension; 1994 Nov; 24(5):611-9. PubMed ID: 7960022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward.
    Rezayof A; Zatali H; Haeri-Rohani A; Zarrindast MR
    Behav Brain Res; 2006 Jan; 166(2):281-90. PubMed ID: 16191443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mecamylamine, nicotine, atropine and physostigmine on the phencyclidine-induced behavioral toxicity.
    Chaturvedi AK
    Pharmacol Biochem Behav; 1984 Apr; 20(4):559-66. PubMed ID: 6728872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1993 Jul; 266(1):329-38. PubMed ID: 8101218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice.
    Tani Y; Saito K; Tsuneyoshi A; Imoto M; Ohno T
    Psychopharmacology (Berl); 1997 Feb; 129(3):225-32. PubMed ID: 9084060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia.
    Sienkiewicz-Jarosz H; Członkowska AI; Siemiatkowski M; Maciejak P; Szyndler J; Płaźnik A
    J Neural Transm (Vienna); 2000; 107(12):1403-12. PubMed ID: 11458993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of nucleus accumbens in nicotine-induced locomotor activity.
    Fung YK
    J Pharm Pharmacol; 1990 Aug; 42(8):595-6. PubMed ID: 1981594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of THA and physostigmine on spatial navigation and avoidance performance in mecamylamine and PCPA-treated rats.
    Riekkinen M; Riekkinen P
    Exp Neurol; 1994 Jan; 125(1):111-8. PubMed ID: 8307118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.
    Clarke PB; Reuben M; el-Bizri H
    Br J Pharmacol; 1994 Mar; 111(3):695-702. PubMed ID: 8019748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.
    Damaj MI; Fei-Yin M; Dukat M; Glassco W; Glennon RA; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1058-65. PubMed ID: 9495867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholinergic drugs on learning impairment in ventral globus pallidus-lesioned rats.
    Ueki A; Miyoshi K
    J Neurol Sci; 1989 Mar; 90(1):1-21. PubMed ID: 2723670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra.
    Levin ED; Briggs SJ; Christopher NC; Auman JT
    Brain Res; 1994 Sep; 657(1-2):165-70. PubMed ID: 7820615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory pathways and sites of action of intrathecally administered nicotinic agents.
    Khan IM; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1550-7. PubMed ID: 7996469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locomotor activity in rats after administration of nicotinic agonists intracerebrally.
    Reavill C; Stolerman IP
    Br J Pharmacol; 1990 Feb; 99(2):273-8. PubMed ID: 2328395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems.
    Naguib M; Yaksh TL
    Anesthesiology; 1994 Jun; 80(6):1338-48. PubMed ID: 8010479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.